Authors:
Moitessier, N
Dufour, S
Chretien, F
Thiery, JP
Maigret, B
Chapleur, Y
Citation: N. Moitessier et al., Design, synthesis and preliminary biological evaluation of a focused combinatorial library of stereodiverse carbohydrate-scaffold-based peptidomimetics, BIO MED CH, 9(2), 2001, pp. 511-523
Citation: Jc. Soetens et al., Molecular Dynamics simulation and X-ray diffraction studies of ethylene carbonate, propylene carbonate and dimethyl carbonate in liquid phase, J MOL LIQ, 92(3), 2001, pp. 201-216
Authors:
Tairi-Kellou, S
Cartier, A
Maouche, B
Maigret, B
Citation: S. Tairi-kellou et al., Electronic descriptors of the (1,4)-benzodiazepine derivatives related to the antagonist activity on cholecystokinin receptors, J MOL ST-TH, 571, 2001, pp. 207-223
Authors:
Xia, BY
Cai, WS
Shao, XG
Guo, QX
Maigret, B
Pan, ZX
Citation: By. Xia et al., Chiral recognition study for the inclusion complexes of amino acids with alpha-cyclodextrin using a fast annealing evolutionary algorithm, J MOL ST-TH, 546, 2001, pp. 33-38
Authors:
Cai, WS
Xia, BY
Shao, XG
Guo, QX
Maigret, B
Pan, ZX
Citation: Ws. Cai et al., Molecular interactions of alpha-cyclodextrin inclusion complexes using a genetic algorithm, J MOL ST-TH, 535, 2001, pp. 115-119
Authors:
Marie, J
Richard, E
Pruneau, D
Paquet, JL
Siatka, C
Larguier, R
Ponce, C
Vassault, P
Groblewski, T
Maigret, B
Bonnafous, JC
Citation: J. Marie et al., Control of conformational equilibria in the human B-2 bradykinin receptor - Modeling of nonpeptidic ligand action and comparison to the rhodopsin structure, J BIOL CHEM, 276(44), 2001, pp. 41100-41111
Authors:
Cai, WS
Xia, BY
Shao, XG
Guo, QX
Maigret, B
Pan, ZX
Citation: Ws. Cai et al., Molecular docking of alpha-cyclodextrin inclusion complexes by genetic algorithm and empirical binding free energy function, CHEM P LETT, 342(3-4), 2001, pp. 387-396
Authors:
Moitessier, N
Maigret, B
Chretien, F
Chapleur, Y
Citation: N. Moitessier et al., Molecular dynamics-based models explain the unexpected diastereoselectivity of the sharpless asymmetric dihydroxylation of allyl D-xylosides, EUR J ORG C, (6), 2000, pp. 995-1005
Authors:
Magalhaes, AL
Maigret, B
Gomes, JANF
Ramos, MJ
Citation: Al. Magalhaes et al., Hybrid QM/MM study of a fundamental biological interaction surrounded by its protein environment, INTERNET J, 3(9-11), 2000, pp. NIL_43-NIL_55
Citation: H. Minoux et al., Structural analysis of the KGD sequence loop of barbourin, an alpha(IIb)beta(3)-specific disintegrin, J COMPUT A, 14(4), 2000, pp. 317-327
Authors:
Bellier, B
Million, ME
DaNascimento, S
Meudal, H
Kellou, S
Maigret, B
Garbay, C
Citation: B. Bellier et al., Replacement of glycine with dicarbonyl and related moieties in analogues of the C-terminal pentapeptide of cholecystokinin: CCK2 agonists displaying a novel binding mode, J MED CHEM, 43(20), 2000, pp. 3614-3623
Authors:
Cai, WS
Xia, BY
Shao, XG
Guo, QX
Maigret, B
Pan, ZX
Citation: Ws. Cai et al., Stability and geometry prediction for the inclusion complexes of mono- or 1,4-disubstituted benzenes and beta-cyclodextrin using a genetic algorithm, CHEM P LETT, 319(5-6), 2000, pp. 708-712
Authors:
Cartier, A
Brown, D
Maigret, B
Boschi-Muller, S
Rahuel-Clermont, S
Branlant, G
Citation: A. Cartier et al., Modelling the active site of glyceraldehyde-3 phosphate dehydrogenase withthe LSCF formalism, THEOR CH AC, 101(1-3), 1999, pp. 241-245
Authors:
Gigoux, V
Maigret, B
Escrieut, C
Silvente-Poirot, S
Bouisson, M
Fehrentz, JA
Moroder, L
Gully, D
Martinez, J
Vaysse, N
Fourmy, D
Citation: V. Gigoux et al., Arginine 197 of the cholecystokinin-A receptor binding site interacts withthe sulfate of the peptide agonist cholecystokinin, PROTEIN SCI, 8(11), 1999, pp. 2347-2354
Authors:
Campagne, F
Jestin, R
Reversat, JL
Bernassau, JM
Maigret, B
Citation: F. Campagne et al., Visualisation and integration of G protein-coupled receptor related information help the modelling: Description and applications of the Viseur program, J COMPUT A, 13(6), 1999, pp. 625-643
Citation: C. Chipot et al., Early events in the folding of an amphipathic peptide: A multinanosecond molecular dynamics study, PROTEINS, 36(4), 1999, pp. 383-399
Authors:
Topham, CM
Mouledous, L
Poda, G
Maigret, B
Meunier, JC
Citation: Cm. Topham et al., Molecular modelling of the ORL1 receptor and its complex with nociceptin (vol 11, pg 1163, 1998), PROTEIN ENG, 12(10), 1999, pp. 893-893
Authors:
Marie, J
Koch, C
Pruneau, D
Paquet, JL
Groblewski, T
Larguier, R
Lombard, C
Deslauriers, B
Maigret, B
Bonnafous, JC
Citation: J. Marie et al., Constitutive activation of the human bradykinin B-2 receptor induced by mutations in transmembrane helices III and VI, MOLEC PHARM, 55(1), 1999, pp. 92-101
Authors:
Silvente-Poirot, S
Escrieut, C
Gales, C
Fehrentz, JA
Escherich, A
Wank, SA
Martinez, J
Moroder, L
Maigret, B
Bouisson, M
Vaysse, N
Fourmy, D
Citation: S. Silvente-poirot et al., Evidence for a direct interaction between the penultimate aspartic acid ofcholecystokinin and histidine 207, located in the second extracellular loop of the cholecystokinin B receptor, J BIOL CHEM, 274(33), 1999, pp. 23191-23197
Authors:
Gigoux, V
Escrieut, C
Fehrentz, JA
Poirot, S
Maigret, B
Moroder, L
Gully, D
Martinez, J
Vaysse, N
Fourmy, D
Citation: V. Gigoux et al., Arginine 336 and asparagine 333 of the human cholecystokinin-A receptor binding site interact with the penultimate aspartic acid and the C-terminal amide of cholecystokinin, J BIOL CHEM, 274(29), 1999, pp. 20457-20464